Select Biosciences
The Market Reports division of Select Biosciences is focused on producing specialist reviews of cutting edge technologies and techniques. Written by experts in their fields, our reports provide a snapshot of dynamic and emerging markets in the biotechnology and drug discovery arena. Typically they include : Executive summary , Technology overview, Applications , Market size & analysis and Review of competing companies.
Your filters
clear all
None selected
previous
| Cellular Therapy and Cord Blood Market Report (SEL00050) 2013This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences. In this comprehensive market report, we have focused primarily... | Feb 2013 | £1,600€1,895$2,491 |
| Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (SEL00049) 2013 Market ReportThis is the latest and most up-to-date Market Report from Select Biosciences addressing the CTC and CSC markets as they are evolving. In this report, we focus upon technical and... | Jan 2013 | £1,600 |
| Companion Diagnostics and Personalized Medicine (SEL00005) 2012Note: This is deliered as a Powerpoint This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace. Personalized medicine is... | Aug 2012 | £1,255€1,486$1,954 |
| MicroRNAs and Exosomes Market Report (SEL00048) 2012Disease Associations and Circulating Biomarkers This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA and Exosomes markets as they are evolving. In this report, we... | Aug 2012 | £1,255€1,486$1,954 |
| MicroRNA Market Trends (SEL00036) 2011This is the latest and most up-to-date Market Report from Select Biosciences addressing the microRNA research space. In this report, we focus upon the microRNA marketplace via primary market research... | Oct 2011 | £1,080€1,279$1,681 |
| Circulating Tumor Cells (CTCs)Market Trends (SEL00042) 2011This is the latest and most up-to-date Market Report from Select Biosciences addressing the circulating tumor cells (CTCs) space. In this report, we focus upon the emerging marketplace for the... | Jul 2011 | £1,067€1,264$1,661 |
| Umbilical Cord Blood Banking Market Trends (SEL00041) 2011This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative... | Jun 2011 | £880€1,042$1,370 |
| Single Cell Omics (SEL00043) 2011The single cell Omics revolution is the potential transformation of cellular heterogeneity from a source of noise to a source of new, as yet hidden discoveries. No longer will the... | May 2011 | £2,315€2,742$3,604 |
| Adult Stem Cells Market Trends 2011 (SEL00032) This is the latest and most up-to-date Market Report from Select Biosciences addressing the adult stem cells marketplace. In this report, we focus upon adult stem cells (especially mesenchymal... | Jan 2011 | £1,500€1,777$2,335 |
| Cancer Vaccines & Circulating Tumor Cells (CTCs) (SEL00044) 2011 ReportThis market report from Select Biosciences presents a comprehensive industry analysis of the cancer vaccines space as well as that of the emerging circulating tumor cells (CTCs) space. These two... | Jan 2011 | £1,680€1,990$2,615 |
| Epigenetics Market Trends (SEL00045) 2011This is the latest and most up-to-date Market Report from Select Biosciences addressing the expanding epigenetics marketplace. Epigenetics research efforts are growing around the world driven by the numerous documented... | Jan 2011 | £1,055€1,250$1,642 |
| Multiplexed Diagnostics 2010 (SEL00040) Market ReportThe multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. Will the FDA finally release the... | May 2010 | £2,275€2,695$3,541 |
| Stem Cells Market Trends 2010 (SEL00046) Drug Discovery/Toxicity Screening and Regenerative MedicineThis market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a... | Apr 2010 | £1,015€1,202$1,580 |
| Adult Stem Cells and iPSCs 2010 (SEL00047) Market ReportThis market report from Select Biosciences comprehensively addresses the technology and market landscape governing adult stem cells as well as induced pluripotent stem cells (iPSCs). Adult stem cells currently underlie... | Mar 2010 | £1,255€1,486$1,954 |
| MicroRNA Research and Disease Associations 2010 Market Report (SEL00033) This is the latest and most up-to-date Market Report from Select Biosciences addressing MicroRNA Research Market Trends - both qualitative and quantitative trends including market size, growth rate, and projections.... | Jan 2010 | £1,800€2,132$2,802 |
| Stem Cells for Cellular Therapy 2010 Market Report (SEL00034) This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences' industry coverage of the stem cells space is broad and comprehensive-each... | Jan 2010 | £1,625€1,925$2,530 |
| Single Cell Analysis 2010 (SEL00035) The New Frontier for 'Omics Market ReportOmics has unleashed a deluge of data that underscores the complexity of biological systems. Simplification and specificity is the new dogma, and one of the most promising approaches is single... | Jan 2010 | £2,315€2,742$3,604 |
| MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report (SEL00037) This is the latest and most up-to-date Market Analysis Report from Select Biosciences addressing MicroRNA Diagnostics, Therapeutics and Cancer Personalized Medicine. The Cancer Personalized Medicine Marketplace Provides a Paradigm for... | Jul 2009 | £1,800€2,132$2,802 |
| Toxicity Screening 2009 Market Report (SEL00038) Abstract This is the latest and most up-to-date Toxicity Screening Market Analysis Report from Select Biosciences. This comprehensive report provides a qualitative and quantitative analysis of the toxicity screening space, market... | Feb 2009 | £1,800€2,132$2,802 |
| Biotechnology Business Plan Writing Guide 2009 (SEL00039) With a faltering pharmaceutical industry, inefficient health care, a global recession and a change of administration in Washington, D.C., biotechnology is entering a new era. On one side is greater... | Feb 2009 | £335€397$521 |
| Stem Cells for Cardiovascular Disease 2009 Market Report (SEL00031) This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences, based on our continual industry coverage. Select Biosciences industry coverage in this report focuses on... | Jan 2009 | £2,000€2,369$3,113 |
| Compound Management Trends 2008 (SEL00003) This market report summarizes the results of HTStec's second global pharma and biotech web-based benchmarking survey on compound management carried out in January 2008. The study was initiated to gain a... | Jul 2008 | £1,540€1,824$2,397 |
| Cancer Personalized Medicine 2008 (SEL00004) This is the latest most up-to-date Cancer Personalized Medicine Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Cancer Personalized Medicine Marketplace based upon... | Jul 2008 | £2,425€2,872$3,775 |
| Epigenetics and MicroRNA Diagnostics/Therapeutics 2008 (SEL00006) This is the latest Epigenetics and MicroRNA Diagnostics/Therapeutics Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Epigenetics Marketplace based upon our continuing industry... | May 2008 | £2,350€2,783$3,658 |
| Kinase Screening & Profiling Trends 2008 (SEL00001) This market report summarizes the results of HTStec's third global pharma and biotech web-based benchmarking survey on kinase screening and profiling carried out in May 2008 The objective was to document... | May 2008 | £1,540€1,824$2,397 |
